Eva Markert
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Bone Tumor Diagnosis and Treatments
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Sarcoma Diagnosis and Treatment 4
- Prostate Cancer Treatment and Research 2
- Lung Cancer Treatments and Mutations 2
-
- Rheumatoid Arthritis Research and Therapies 3
- Bone Tumor Diagnosis and Treatments 2
- Urologic and reproductive health conditions 1
- Co-authors
- Lukas Flatz (2 shared papers)Stefan Diem (2 shared papers)Omar Hasan Ali (2 shared papers)Daniel E. Speiser (1 shared paper)Martin Früh (1 shared paper)Wolfram Jochum (1 shared paper)Lars E. French (1 shared paper)Katrin Kerl (1 shared paper)
- Journals
- Lara D. Veeken (2 papers)Urologic Oncology Seminars and Original Investigations (1 paper)Journal of Thoracic Oncology (1 paper)Cancer Immunology Immunotherapy (1 paper)The American Journal of Surgical Pathology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Eva Markert
18 papers receiving 412 citations
Peers
Comparison fields: 5 of 46
- Rheumatology 129
- Oncology 142
- Pulmonary and Respiratory Medicine 135
- Cancer Research 45
- Oral Surgery 20
Countries citing papers authored by Eva Markert
This map shows the geographic impact of Eva Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Markert more than expected).
Fields of papers citing papers by Eva Markert
This network shows the impact of papers produced by Eva Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Markert. The network helps show where Eva Markert may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Markert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 99 | |
| 2 | 2011 | 98 | |
| 3 | 1998 | 53 | |
| 4 | 2019 | 48 | |
| 5 | 1997 | 27 | |
| 6 | 1997 | 16 | |
| 7 | Association of (Q)R/KRAA positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis. | 1999 | 15 |
| 8 | Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction. | 1996 | 15 |
| 9 | 2010 | 12 | |
| 10 | 2022 | 9 | |
| 11 | Enhanced proliferation and decreased apoptosis in lung lavage cells of sarcoidosis patients. | 2006 | 7 |
| 12 | 2020 | 6 | |
| 13 | 2006 | 5 | |
| 14 | 2009 | 5 | |
| 15 | 2009 | 2 | |
| 16 | 2008 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2008 | 0 | |
| 20 | 2023 | 0 |
About Eva Markert
Eva Markert is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Oncology, Molecular Biology and Immunology, having authored 20 papers that have together received 421 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Bone Tumor Diagnosis and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers), Prostate Cancer Treatment and Research (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Urologic and reproductive health conditions (1 paper). The work is most often cited by research in Rheumatology (129 citations), Oncology (142 citations), Pulmonary and Respiratory Medicine (135 citations), Cancer Research (45 citations) and Oral Surgery (20 citations). Eva Markert has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Lukas Flatz, Stefan Diem, Omar Hasan Ali, Daniel E. Speiser, Martin Früh, Wolfram Jochum, Lars E. French, Katrin Kerl, Christian Seidl and Ute Koch. Their work appears in journals such as Lara D. Veeken, Urologic Oncology Seminars and Original Investigations, Journal of Thoracic Oncology, Cancer Immunology Immunotherapy and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.